Filing Flows › Comparisons › ACT vs SLQT
Enact Holdings vs SelectQuote: ACT and SLQT compared
Enact Holdings is the larger company: $313M of revenue in its latest quarter (Q3 2026) against $280M for SelectQuote (Q1 FY27). Enact Holdings is growing faster (+0.4% against -15% a year earlier). Enact Holdings is more profitable, with an operating margin of 64.9% against -10.2%.
Where the money goes: ACT and SLQT
Enact Holdings (ACT) · Q3 2026
Enact Holdings, Q3 2026: revenue $313M (+0.4% year over year), operating margin 64.9%, net earnings $159M, operating cash flow $184M. The chart follows the revenue to costs, profit and cash.
SelectQuote (SLQT) · Q1 FY27
SelectQuote, Q1 FY27: revenue $280M (-15% year over year), operating margin -10.2%, net loss $20.3M, operating cash flow −$17.2M. The chart follows the revenue to costs, profit and cash.
| Enact Holdings (ACT) | SelectQuote (SLQT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $313M | $280M |
| Revenue growth, Y/Y | +0.4% | -15% |
| Operating margin | 64.9% | -10.2% |
| Net earnings | $159M | −$20.3M |
| Net margin | 50.8% | -7.3% |
| Operating cash flow | $184M | −$17.2M |
| Market value | $6.7B | $68.0M |
| P/E | 9.8× | — |
| Analysts’ mean target | $47.20 | $2.09 |
Where the revenue comes from
SelectQuote
- Pharmacy: $184M (66%)
- Service: $96.0M (34%)
Questions
Which is bigger, Enact Holdings or SelectQuote?
Enact Holdings is the larger company: $313M of revenue in its latest quarter (Q3 2026) against $280M for SelectQuote (Q1 FY27).
Is Enact Holdings or SelectQuote growing faster?
Enact Holdings is growing faster (+0.4% against -15% a year earlier).
Which is more profitable, Enact Holdings or SelectQuote?
Enact Holdings is more profitable, with an operating margin of 64.9% against -10.2%.
More: Enact Holdings earnings · how Enact Holdings makes money · SelectQuote earnings · how SelectQuote makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.